Fresenius Can't Kill Nausea Drug IP Claims As Indefinite
By Adam Lidgett ( August 1, 2023, 5:18 PM EDT) -- Fresenius Kabi USA LLC lost its argument in Delaware federal court that some claims in several Heron Therapeutics nausea drug patents that it is accused of infringing are invalid as indefinite....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.